Balchem Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Balchem wird ein jährliches Gewinn- und Umsatzwachstum von 14.9% bzw. 5.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 14.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.1% betragen.

Wichtige Informationen

14.9%

Wachstumsrate der Gewinne

14.4%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	16.7%
Wachstumsrate der Einnahmen	5.4%
Zukünftige Eigenkapitalrendite	12.1%
Analystenabdeckung	Low
Zuletzt aktualisiert	04 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Jul 31

Recent updates

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Jul 31

Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Jun 29

Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable

Jun 15

Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Jun 10

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

May 26

Balchem: A Tale Of Two Businesses

May 10

Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Mar 21

Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Mar 05

Balchem: Potential Turnaround Is In The Price

Feb 21

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Feb 18

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Jan 03

Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Dec 19

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Nov 20

Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

Oct 19

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

Sep 09

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 22

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Jul 19

Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

May 28

Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

May 12

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Apr 12

We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Mar 14

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Jan 11

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Dec 29

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Dec 13

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Nov 29

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Sep 20

Balchem: Acquisitions And Cost Pressures Draw Attention

Sep 12

Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly

Sep 05

Balchem to acquire Cardinal Associates or Bergstrom Nutrition

Aug 30

Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?

Aug 22

Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

Aug 08

Balchem Q2 2022 Earnings Preview

Jul 28

Balchem: On The M&A Road Again

Jun 28

Balchem: A New Growth Stage Is Just Beginning

Jun 02

Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement

May 30

Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price

May 18

Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?

May 02

Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?

Mar 28

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Feb 26

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:BCPC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,055	169	188	230	1
12/31/2025	1,016	152	176	216	3
12/31/2024	954	131	136	173	3
9/30/2024	942	122	162	197	N/A
6/30/2024	932	117	159	192	N/A
3/31/2024	930	115	147	182	N/A
12/31/2023	922	109	146	184	N/A
9/30/2023	926	103	118	158	N/A
6/30/2023	941	99	106	153	N/A
3/31/2023	946	99	117	166	N/A
12/31/2022	942	105	89	139	N/A
9/30/2022	923	109	91	141	N/A
6/30/2022	877	109	95	139	N/A
3/31/2022	842	102	86	127	N/A
12/31/2021	799	96	123	161	N/A
9/30/2021	767	93	128	164	N/A
6/30/2021	744	90	125	160	N/A
3/31/2021	715	88	134	169	N/A
12/31/2020	704	85	117	150	N/A
9/30/2020	689	83	108	136	N/A
6/30/2020	673	82	116	143	N/A
3/31/2020	661	81	99	125	N/A
12/31/2019	644	80	96	124	N/A
9/30/2019	641	80	103	131	N/A
6/30/2019	637	78	94	121	N/A
3/31/2019	639	78	91	116	N/A
12/31/2018	644	79	99	119	N/A
9/30/2018	639	100	87	110	N/A
6/30/2018	635	97	N/A	112	N/A
3/31/2018	618	94	N/A	113	N/A
12/31/2017	595	90	N/A	111	N/A
9/30/2017	576	64	N/A	107	N/A
6/30/2017	564	62	N/A	97	N/A
3/31/2017	556	60	N/A	101	N/A
12/31/2016	553	56	N/A	108	N/A
9/30/2016	545	56	N/A	105	N/A
6/30/2016	547	56	N/A	110	N/A
3/31/2016	543	56	N/A	107	N/A
12/31/2015	552	60	N/A	104	N/A
9/30/2015	582	63	N/A	115	N/A
6/30/2015	603	64	N/A	108	N/A
3/31/2015	600	59	N/A	102	N/A
12/31/2014	541	53	N/A	85	N/A
9/30/2014	460	45	N/A	65	N/A
6/30/2014	387	41	N/A	60	N/A
3/31/2014	339	43	N/A	62	N/A
12/31/2013	337	45	N/A	56	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BCPCDas prognostizierte Gewinnwachstum (14.9% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: BCPCDie Erträge des Unternehmens (14.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.3% pro Jahr).

Hohe Wachstumserträge: BCPCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: BCPCDie Einnahmen des Unternehmens (5.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: BCPCDie Einnahmen des Unternehmens (5.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BCPCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.1%).

Balchem Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Price target increased by 11% to US$184

Price target increased by 14% to US$166

Price target decreased by 8.4% to US$145

Price target increased to US$170

Recent updates

Now 22% overvalued after recent price rise

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Third quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem Corporation Announces Resignation of Joyce Lee as Director

Balchem Corporation to Report Q3, 2024 Results on Oct 25, 2024

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) Using Too Much Debt?

Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today

Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon

VP & Chief Accounting Officer notifies of intention to sell stock

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Price target increased by 11% to US$184

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Balchem Corporation to Report Q2, 2024 Results on Jul 26, 2024

Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable

Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Insider notifies of intention to sell stock

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Independent Director recently sold US$765k worth of stock

Independent Director notifies of intention to sell stock

Balchem: A Tale Of Two Businesses

Price target increased by 14% to US$166

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% overvalued after recent price rise

Balchem Corporation, Annual General Meeting, Jun 20, 2024

Balchem Corporation to Report Q1, 2024 Results on May 03, 2024

Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Chairman recently sold US$4.6m worth of stock

Chairman notifies of intention to sell stock

Balchem: Potential Turnaround Is In The Price

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Full year 2023 earnings: EPS misses analyst expectations

Now 21% overvalued after recent price rise

Balchem Corporation to Report Q4, 2023 Results on Feb 16, 2024

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Upcoming dividend of US$0.79 per share at 0.5% yield

Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Balchem Corporation Announces Dividend, Payable on January 19, 2024

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Price target decreased by 8.4% to US$145

Third quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

Balchem Corporation to Report Q3, 2023 Results on Oct 27, 2023

Independent Director recently sold US$500k worth of stock

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

Balchem Corporation Announces Board Appointments, Effective as of September 6, 2023

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation to Report Q2, 2023 Results on Jul 28, 2023

Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Senior VP & CTO recently sold US$300k worth of stock

First quarter 2023 earnings: EPS exceeds analyst expectations

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Independent Director recently sold US$381k worth of stock

We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Full year 2022 earnings: EPS misses analyst expectations

Balchem Corporation to Report Q4, 2022 Results on Feb 24, 2023

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Upcoming dividend of US$0.71 per share

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation Announces Dividend, Payable on January 20, 2023

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Insufficient new directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind